Through K–M survival analysis, we found that BLCA patients with low CTSE expression had significantly worse OS, DSS and PFI than BLCA patients with high CTSE expression (Fig. 11E–G). The gene discussed is CTSE; the disease is bladder transitional cell carcinoma.